KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Current Deferred Revenue (2017 - 2020)

Novartis Ag's Current Deferred Revenue history spans 4 years, with the latest figure at $56.0 million for Q4 2020.

  • For Q4 2020, Current Deferred Revenue fell 50.88% year-over-year to $56.0 million; the TTM value through Dec 2020 reached $56.0 million, down 50.88%, while the annual FY2020 figure was $56.0 million, 50.88% down from the prior year.
  • Current Deferred Revenue for Q4 2020 was $56.0 million at Novartis Ag, down from $114.0 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $305.0 million in Q4 2017 and bottomed at $56.0 million in Q4 2020.
  • The 4-year median for Current Deferred Revenue is $175.0 million (2018), against an average of $177.8 million.
  • The largest annual shift saw Current Deferred Revenue dropped 22.62% in 2018 before it crashed 51.69% in 2019.
  • A 4-year view of Current Deferred Revenue shows it stood at $305.0 million in 2017, then dropped by 22.62% to $236.0 million in 2018, then plummeted by 51.69% to $114.0 million in 2019, then plummeted by 50.88% to $56.0 million in 2020.
  • Per Business Quant, the three most recent readings for NVS's Current Deferred Revenue are $56.0 million (Q4 2020), $114.0 million (Q4 2019), and $236.0 million (Q4 2018).